Table I.
Clinical and demographic features of 37 children with cancer who developed PRES
| Gender Male: Female | 21:16 |
| Median age at cancer diagnosis | 9 years (range 1 to 17.5) |
| Median time to PRES | 6.6 months (0 to 101.4) |
| Tumor type | |
| Leukemia: | 25 |
| Brain tumor | 5 |
| Other solid tumor | 7 |
| Relapsed Leukemia | 8 |
| Hypertension: | |
| Borderline | 1 |
| Definite | 35 |
| Chemotherapy within 14 days | 21 |
| Radiation: | |
| Total body | 9 |
| Brain | 7 |
| Calcineurin inhibitors | 9 |
| Steroids | 29 |
| BMI: | |
| 20–25: | 5 |
| >25 | 6 |
| Headache | 15 |
| Seizures | 36 |
| Breakthrough seizures | 9 |
| Vision impairment | 10 |
| Altered mental status | 25 |
| Recurrent PRES | 2 |
PRES) posterior reversible encephalopathy syndrome, TBI) total body irradiation, BMI) body mass index